Economics of lower urinary tract symptoms (LUTS) in older people

Drugs and Aging

Volumn 18, Issue 3, 2001, Pages 213-223

  Azam, Usman ^a   Castleden, Mark ^b   Turner, David ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFALEXIN; CONJUGATED ESTROGEN; ERYTHROMYCIN; ESTRADIOL; ESTRIOL; ESTROGEN; IMIPRAMINE; NALIDIXIC ACID; NITROFURANTOIN; ORTHO DINOESTROL; OXYBUTYNIN; PROPIVERINE; TAMPOVAGAN; TOLTERODINE; TRIMETHOPRIM;

COST OF ILLNESS; DETRUSOR DYSSYNERGIA; DISEASE SEVERITY; GERIATRIC CARE; HEALTH ECONOMICS; HEALTH SERVICES RESEARCH; HORMONE SUBSTITUTION; HUMAN; NOCTURIA; ORTHOSTATIC HYPOTENSION; PAIN; PRIORITY JOURNAL; REVIEW; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE INCONTINENCE; XEROSTOMIA;

AGED; COST OF ILLNESS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; QUALITY OF LIFE; URINARY BLADDER DISEASES; URINARY INCONTINENCE; URINARY TRACT INFECTIONS; URINARY TRACT PHYSIOLOGY; URINATION DISORDERS;

EID: 0035072205     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118030-00006     Document Type: Review

References (65)

1. Incontinence campaign tests limits of advertising rules
2. New words for old: Lower urinary tract symptoms for 'prostatism'
3. International Continence Society 'Benign Prostatic Hyperplasia' study: Background, aims and methodology
4. The International Continence Society 'Benign Prostatic Hyperplasia' study: The bothersomeness of urinary symptoms
5. The epidemiology of incontinence in the elderly
6. Prevalence and incidence of urinary incontinence in community-dwelling populations
7. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly
8. Epidemiology of urinary incontinence: Prevalence, incidence and correlates in community populations
9. Urinary incontinence in elderly nursing home patients
10. Prevalence of urinary and faecal incontinence in hospitals and residential and nursing homes for older people
11. Epidemiology of female urinary incontinence, classification of urinary incontinence, urinary incontinence in elderly women
12. Handicaps associated with incontinence: Implications for management
13. Urinary incontinence and urinary tract infections in octogenarian women
14. Prostatism and the burden of benign prostatic hyperplasia on elderly men
15. Pelvic floor exercises as a treatment for post-micturition dribble
16. Voiding pattern of men 60 to 70 years old: Population study in an urban population
17. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women
18. The prevalence of urinary incontinence or prolapse among white and Hispanic women
19. Health economics
20. Economic costs of urinary incontinence in 1995
21. The economic impact of urinary incontinence
22. Characteristics of elderly nursing home residents: Data from the 1995 National Nursing Home Survey
23. Recommendations of the Panel on Cost-effectiveness in Health and Medicine
24. Economic considerations and outcome measurement in urge incontinence
25. Background theory
26. Willingness to pay for reduced incontinence symptoms
27. EuroQol - A new facility for the measurement of health related quality of life
28. Challenges in the economic evaluation of incontinence services
29. Pyelonephritis and bacteriuria: A major problem in preventative medicine
30. The management of urinary incontinence in the elderly
31. Urinary tract infections 5.1.18
32. Terociline with bladder retraining for treating detrusor instability in elderly people
33. Oxybutynin with bladder retraining for detrusor instability in elderly people: A randomized controlled trial
34. Efficacy of bladder training in older women with urinary incontinence
35. Double-blind study of imipramine and placebo for incontinence due to bladder instability
36. Imipramine: A possible alternative to current therapy for urinary incontinence in the elderly
37. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria
38. The pharmacology and pharmokinetics of oxybutynin
39. Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers
40. Low dose oxybutynin for the unstable bladder
41. Controlled-release oxybutynin maintains efficacy with a 43% reduction side effects compared with conventional oxybutynin treatment
42. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis
43. Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder
44. The comparative tolerability of oxybutynin and tolterodine: The role of downward titration
45. Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle
46. Clinical effectiveness of propiverine hydrochloride in the treatment of urinary frequency and incontinence associated with detrusor overactivity: A double-blind, parallel, placebo-controlled, multicenter study
47. Double-blind, placebo-controlled clinical study of propiverine in patients suffering from detrusor hyperreflexia
48. Biochemical composition of collagen in continent and stress urinary incontinent women
49. Changes in urethral cytology following estrogen administration
50. Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis. First report of the Hormones and Urogenital Therapy Committee
51. Oestriol in the treatment of postmenopausal urgency: A multicentre study
52. Efficacy of estrogen supplementation in the treatment of urinary incontinence: The Continence Program for Women Research Group
53. Characterisation of detrusor contractile function in relation to old age
54. Post operative urinary retention in women: Management of intermittent catheterisation
55. The development of a comprehensive instructional package for teaching intermittent self catheterisation
56. The clinical performance of incontinence products in relation to technical testing
57. Tecnical testing and user requirement for adult incontinence products
58. Catheters and collecting systems
59. Pads and pants
60. Prevention of urinary incontinence in older people